Indeed, the neutralizing anti-LIGHT mAb induced a dose-dependent inhibition of osteoclastogenesis spontaneously occurring in both the above cultures derived from MM-bone disease patients. The gene discussed is TNFSF14; the disease is Miyoshi myopathy.